GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More
Nestle SA headquartered in Switzerland, is the world's leading nutrition, health and wellness company. Its product portfolio consists of coffee, water, dairy, ice cream, infant nutrition, performance nutrition, healthcare nutrition, chocolate, frozen... More
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GSK CONSUMER Mar-19 |
NESTLE Dec-14 |
GSK CONSUMER/ NESTLE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 7,819 | 5,944 | - | |
Low | Rs | 5,832 | 5,182 | - | |
Sales per share (Unadj.) | Rs | 1,136.9 | 2,351.1 | - | |
Earnings per share (Unadj.) | Rs | 233.7 | 370.0 | - | |
Cash flow per share (Unadj.) | Rs | 248.1 | 501.1 | - | |
Dividends per share (Unadj.) | Rs | 105.00 | 178.40 | - | |
Dividend yield (eoy) | % | 1.5 | 3.2 | 48.0% | |
Book value per share (Unadj.) | Rs | 973.5 | 1,794.9 | - | |
Shares outstanding (eoy) | m | 42.06 | 3,168.40 | - | |
Bonus/Rights/Conversions | - | OI | - | ||
Price / Sales ratio | x | 6.0 | 2.4 | 253.7% | |
Avg P/E ratio | x | 29.2 | 15.0 | 194.3% | |
P/CF ratio (eoy) | x | 27.5 | 11.1 | 247.9% | |
Price / Book Value ratio | x | 7.0 | 3.1 | 226.2% | |
Dividend payout | % | 44.9 | 48.2 | 93.2% | |
Avg Mkt Cap | Rs m | 287,083 | 17,625,093 | 1.6% | |
No. of employees | `000 | 3.8 | 339.0 | 1.1% | |
Total wages/salary | Rs m | 6,446 | 1,307,657 | 0.5% | |
Avg. sales/employee | Rs Th | 12,440.2 | 21,974.4 | 56.6% | |
Avg. wages/employee | Rs Th | 1,677.0 | 3,857.4 | 43.5% | |
Avg. net profit/employee | Rs Th | 2,556.7 | 3,457.9 | 73.9% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 47,820 | 7,449,333 | 0.6% | |
Other income | Rs m | 4,326 | 32,355 | 13.4% | |
Total revenues | Rs m | 52,146 | 7,481,688 | 0.7% | |
Gross profit | Rs m | 11,410 | 1,927,428 | 0.6% | |
Depreciation | Rs m | 606 | 415,586 | 0.1% | |
Interest | Rs m | 8 | 62,601 | 0.0% | |
Profit before tax | Rs m | 15,123 | 1,481,595 | 1.0% | |
Minority Interest | Rs m | 0 | -36,328 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 5,295 | 273,030 | 1.9% | |
Profit after tax | Rs m | 9,828 | 1,172,237 | 0.8% | |
Gross profit margin | % | 23.9 | 25.9 | 92.2% | |
Effective tax rate | % | 35.0 | 18.4 | 190.0% | |
Net profit margin | % | 20.6 | 15.7 | 130.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 52,674 | 2,753,897 | 1.9% | |
Current liabilities | Rs m | 18,140 | 2,667,456 | 0.7% | |
Net working cap to sales | % | 72.2 | 1.2 | 6,223.5% | |
Current ratio | x | 2.9 | 1.0 | 281.3% | |
Inventory Days | Days | 36 | 36 | 97.5% | |
Debtors Days | Days | 29 | 53 | 55.0% | |
Net fixed assets | Rs m | 4,798 | 2,304,659 | 0.2% | |
Share capital | Rs m | 421 | 26,111 | 1.6% | |
Net worth | Rs m | 40,947 | 5,686,842 | 0.7% | |
Long term debt | Rs m | 0 | 1,005,192 | 0.0% | |
Total assets | Rs m | 60,681 | 2,712,461 | 2.2% | |
Interest coverage | x | 1,939.8 | 24.7 | 7,864.1% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.8 | 2.7 | 28.7% | |
Return on assets | % | 16.2 | 45.5 | 35.6% | |
Return on equity | % | 24.0 | 20.6 | 116.4% | |
Return on capital | % | 37.0 | 22.5 | 164.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 6,711 | 1,192,023 | 0.6% | |
From Investments | Rs m | -3,351 | -249,108 | 1.3% | |
From Financial Activity | Rs m | -3,768 | -862,554 | 0.4% | |
Net Cashflow | Rs m | -408 | 80,360 | -0.5% |
Compare GSK CONSUMER With: TIGER BRANDS (S. Africa) COCA COLA (US) AVI LTD. (S. Africa)
Compare GSK CONSUMER With: UNITED BREWERIES RAJ OIL MILLS LAKSHMI OVERSEAS IND. SAVITA OIL VENKYS
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
Does the company with one of the fastest-growing QSR chains in India have sound prospects?
For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.
For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More